reveragen.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: Scrapy Allow: / User-agent: * Disallow: /wp-content/uploads/wpo-plugins-tables-list.json # START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.reveragen.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Home - ReveraGen |
| Description | We are a drug development company engaged in the discovery and development of proprietary therapeutic products for neuromuscular and inflammatory |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 64.92.125.42 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
reveragen.com Valuation
|
US$3,690,637
Last updated: 2023-05-03 16:26:18
reveragen.com has Semrush global rank of 2,867,880. reveragen.com has an estimated worth of US$ 3,690,637, based on its estimated Ads revenue. reveragen.com receives approximately 425,843 unique visitors each day. Its web server is located in United States, with IP address 64.92.125.42. According to SiteAdvisor, reveragen.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,690,637 |
| Daily Ads Revenue | US$3,407 |
| Monthly Ads Revenue | US$102,203 |
| Yearly Ads Revenue | US$1,226,427 |
| Daily Unique Visitors | 28,390 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| reveragen.com. | A | 3590 | IP: 64.92.125.42 |
| reveragen.com. | NS | 86400 | NS Record: ns3.bdm.microsoftonline.com. |
| reveragen.com. | NS | 86400 | NS Record: ns4.bdm.microsoftonline.com. |
| reveragen.com. | NS | 86400 | NS Record: ns1.bdm.microsoftonline.com. |
| reveragen.com. | NS | 86400 | NS Record: ns2.bdm.microsoftonline.com. |
| reveragen.com. | MX | 3600 | MX Record: 0 reveragen-com.mail.protection.outlook.com. |
| reveragen.com. | TXT | 3600 | TXT Record: mscid=iCwq3goleIE0kBxAuEB8YjSLeADq3GC0f1P0/3QjMUUTX1ziHAPks7YQHrW1oRh2xaCkXyX9F8pzB8eGncP9uQ== |
| reveragen.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-03 16:26:18
| X About Us Overview Management Board of Directors Partnerships Vamorolone Overview Mechanism of Action Duchenne Muscular Dystrophy and Disease Progression Studies in Cells and Mice Other possible Indications for vamorolone* Clinical Trials Overview Phase 2b Expanded Access Policy Research Pharmacodynamic Biomarkers Chronotherapy microRNA Modulation News Press Releases Publications Contact About Us Overview Management Board of Directors Partnerships Vamorolone Overview Mechanism of Action Duchenne Muscular Dystrophy and Disease Progression Studies in Cells and Mice Other possible Indications for vamorolone* Clinical Trials Overview Phase 2b Expanded Access Policy Research Pharmacodynamic Biomarkers Chronotherapy microRNA Modulation News Press Releases Publications Contact Leveraging academic medicine into innovative therapies through partnerships Innovations in steroid chemistry, pharmacodynamic biomarkers, clinical trial design, and business models for orphan drug development Clinical |
reveragen.com Whois Information
Domain Name: REVERAGEN.COM Registry Domain ID: 1640928658_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domain.com Registrar URL: http://www.domain.com Updated Date: 2021-02-03T15:22:05Z Creation Date: 2011-02-18T19:12:20Z Registry Expiry Date: 2022-02-18T19:12:20Z Registrar: Domain.com, LLC Registrar IANA ID: 886 Registrar Abuse Contact Email: compliance@domain-inc.net Registrar Abuse Contact Phone: 602-226-2389 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.BDM.MICROSOFTONLINE.COM Name Server: NS2.BDM.MICROSOFTONLINE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T23:49:14Z <<< |